Article
Genetics of tardive dyskinesia: a review of progress over the past decade.
Pharmacogenomics - 1 Jan 2026
Zai Clement C, Thamilselvan Megana, Chernous Francesca, Zai Gwyneth C, Müller Daniel J, Kennedy James L, Tiwari Arun K
Abstract excerpt
Tardive dyskinesia (TD) is a potentially irreversible movement disorder that emerges in a proportion of schizophrenia patients who are prescribed antipsychotic medications. These movements affect mostly the orofacial regions, but may also affect the limbs and other body areas, resulting in significant functional impairment and decreased quality of life. While uncertainty about the pathophysiology of TD persists,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
